Irradiated ONS76 pediatric medulloblastoma cells become senescent; senolytics eliminate them
In this abstract, p53 wild-type, low c-Myc ONS76 medulloblastoma cells became senescent after gamma irradiation, while p53-mutated UW228-3 cells underwent apoptosis; senolytic substances targeted the senescent ONS76 cells. [1]
Automatic summary · not editorially reviewed
The key findings
Craniospinal irradiation improves oncological outcome in pediatric medulloblastoma but is linked to severe short- and long-term side effects such as inflammation and impaired neurocognition. [1]
After gamma irradiation, p53 wild-type, c-Myc-low ONS76 cells became senescent, whereas p53-mutated UW228-3 cells showed apoptosis. [1]
Irradiated ONS76 cells were susceptible to the senolytics Navitoclax, PX-866 and BAY80-6946; the authors propose possible clinical benefits. [1]
The source at a glance
- Study type / format
- In vitro cell study (abstract)
- Population / context
- Cultured pediatric medulloblastoma cell lines ONS76 (p53 wild-type, low c-Myc) and UW228-3 (p53-mutated)
- Summary based on
- Study abstract
- Original publication
- October 8, 2026
Why senescence matters after craniospinal irradiation
The abstract states that craniospinal irradiation is an indispensable part of oncological treatment for pediatric medulloblastoma. It improves oncological outcome but is associated with severe short- and long-term side effects such as inflammation and impaired neurocognition. Senescent cells are named as a potential contributing factor to these issues. This is the stated context for the cell experiments, not a finding about patients.
Supporting source [1]
ONS76 cells senesce, UW228-3 cells die after gamma irradiation
The study reports that p53 wild-type, c-Myc-low-expressing ONS76 medulloblastoma cells underwent senescence, described as a terminal and stable cell cycle arrest, after gamma irradiation. In contrast, p53-mutated UW228-3 cells exhibited apoptosis after the same treatment. ONS76 cells showed cell and nuclei enlargement, an active DNA damage response with stabilized p53 and increased p21, elevated senescence-associated beta-galactosidase activity and lipofuscin accumulation. Knockdown of p53 or p21 with siRNAs abolished the irradiation-mediated senescence. Overexpressing c-Myc partially shifted cells from senescence to cell death, which a caspase inhibitor blocked.
Supporting source [1]
Senolytics acted on irradiated ONS76 cells in this abstract
The irradiation-exposed ONS76 cells were susceptible to senolytic substances named in the abstract: the BCL-2 family inhibitor Navitoclax and the PI3K inhibitors PX-866 and BAY80-6946, which the source says specifically target senescent cells. The authors conclude that using senolytics on irradiated medulloblastoma cells with wild-type p53 and low c-Myc expression may reduce therapeutic side effects, attenuate tumor relapse and potentially minimize craniospinal irradiation doses needed for effective tumor cell elimination. These are stated possibilities, not demonstrated patient outcomes.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Findings come from cultured ONS76 and UW228-3 cell lines, not patients. The proposed reductions in side effects, relapse and irradiation dose are stated possibilities, not demonstrated outcomes.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Sonntag J, Preugschas RL, Jazmati D, Qin N, Neuwahl J, Matuschek C, Remke M, Budach W, Hörner-Rieber J, Sohn D. · europepmc.org · October 8, 2026